• SENSEX 81,444.66
    -138.64 (--0.17%)
  • BANKNIFTY 55,828.75
    114.60 (+0.21%)
  • Hindustan Zinc
    451.50 378.65(%)
  • Garden Reach Sh.
    3,286.00 3,528.00(%)
  • NTPC
    330.65 292.70(%)
  • Vishal Mega Mart
    121.90 96.05(%)
  • Optiemus Infra.
    706.50 873.65(%)
  • Infosys
    1,615.00 1,307.10(%)
  • IndusInd Bank
    855.20 1,550.00(%)
  • Cochin Shipyard
    2,135.60 1,180.45(%)
  • Reliance Power
    66.85 76.49(%)
  • Electronics Mart
    161.25 261.75(%)
  • Sika Interplant
    1,537.30 1,537.30(%)
  • Sterlite Tech.
    101.50 50.70(%)
  • Tata Motors
    668.00 542.55(%)
  • Sky Gold & Diam.
    344.60 126.59(%)
  • Wockhardt
    1,699.55 552.20(%)
  • S C I
    225.85 384.80(%)
  • Mazagon Dock
    3,237.70 1,917.95(%)
  • Reliance Industr
    1,425.55 1,115.55(%)
  • HDFC Bank
    1,935.70 1,996.30(%)
  • Suzlon Energy
    63.80 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shukra Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4083.0
  • ISIN : INE551C01044
13.77 0 (-1.99%)
  • As on 18 Jun 2025 (EOD)

  • Today’s Low

    13.77

  • Today’s High

    13.77

  • Open

    13.77

  • Perv Close

    14.05

  • 52W Low

    5.75

  • 52W High

    27.15

Key Indicators

  • P/E(TTM)

    62.59

  • Mar.Cap (₹Cr.)

    602.96

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.44

  • Debt-Equity Ratio

    -1.99

  • AGM Date

    18-Jun-2025

  • EPS

    0.22

  • P/E Ratio

    62.59

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    602.96

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.79

  • BV (₹)

    1.40

  • Sales( ₹ in Cr.)

    32.59

  • NP (in Cr.)

    9.58

  • NP Var(%)

    -48.0

  • Div%

    0.0

  • CPS (₹)

    0.30

  • EPS (₹)

    0.20

  • Traded Value (₹ in Lakhs)

    602.96

  • 52 Week High

    27.15

  • 52 Week Low

    5.75

  • Price BSE

    14.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    602.96

  • P/C Ratio

    48.70

  • P/E Ratio

    64.00

  • Price Vs.BV

    0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 74.57 58.83 20.49 11.20 13.73 6.61
Excise Duty 0.00 0.00 0.00 0.00 1.89 0.95
Net Sales 74.57 58.83 20.49 11.20 11.84 5.66
Other Income 2.82 1.20 0.08 0.36 0.11 0.04
Stock Adjustments -0.70 0.33 0.73 0.19 0.33 0.17
Total Income 76.69 60.36 21.30 11.75 12.28 5.87
EXPENDITURE :            
Raw Materials 43.78 45.65 11.08 2.96 3.33 1.16
Power and Fuel Cost 0.00 0.00 0.00 1.78 1.64 0.34
Employee Cost 5.02 4.41 4.57 3.75 4.34 1.91
Other Manufacturing Expenses 0.05 0.11 0.17 0.09 0.12 0.06
Selling and Administration Expenses 5.15 3.38 2.44 1.36 1.21 0.71
Miscellaneous Expenses 0.47 0.26 0.07 0.21 0.01 0.00
Employee Benefit Expenses 5.02 4.41 4.57 3.75 4.34 1.91
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 54.46 53.80 18.33 10.14 10.64 4.18
Operating Profit 22.22 6.56 2.97 1.60 1.65 1.69
Interest 0.29 0.28 0.29 0.03 0.00 0.00
Gross Profit 21.93 6.28 2.68 1.57 1.65 1.69
Depreciation 2.05 1.84 1.66 1.47 1.48 0.96
Profit Before Tax 19.88 4.44 1.02 0.10 0.17 0.73
Current Tax 1.36 0.01 0.21 -0.20 0.00 0.15
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.02 0.03 0.06 0.11 0.14 0.12
Reported Net Profit 18.54 4.41 0.75 0.19 0.04 0.46
Extraordinary Items 0.00 0.00 0.00 0.05 0.02 0.00
Adjusted Net Profit 18.54 4.41 0.75 0.14 0.02 0.46
Adjustment below Net Profit -0.02 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 19.11 14.78 14.03 13.85 9.65 9.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.07 0.08 0.00 0.00 0.00 0.00
P & L Balance carried down 37.56 19.11 14.78 14.03 9.69 9.65
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 5.00 5.00 0.00 0.00 5.00
Dividend Per Share(Rs) 1.00 0.50 0.50 0.00 0.00 0.50
Earnings Per Share-Unit Curr 16.93 11.26 4.79 1.20 0.23 2.95
Earnings Per Share(Adj)-Unit Curr 0.42 0.28 0.02 0.01 0.00 0.02
Book Value 52.65 64.63 104.43 99.63 98.43 98.20
Book Value(Adj)-Unit Curr 1.32 1.61 0.54 0.51 0.51 0.51

Shareholding Pattern

  • Promoter Group

    50.96%

  • Public Share Holding

    49.04%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 209,015,600 47.73 209,015,600 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 14,120,000 3.22 14,120,000 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 223,135,600 50.96 223,135,600 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500,000 0.11 500,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 500,000 0.11 500,000 1
2] Non Institution
Bodies Corporate 605,623 0.14 605,613 33
Clearing Members 299,990 0.07 299,990 7
Directors of their Relatives 0 0.00 0 0
Employees 87,680 0.02 0 87
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 168,674,920 38.52 168,674,920 71
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 754,635 0.17 754,635 78
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 15,245,380 3.48 15,245,380 27
Individuals holding nominal share capital up to Rs. 1 lakh 25,421,982 5.81 24,637,782 17,910
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 214,243,840 48.93 213,371,950 18,223
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 437,879,440 100.00 437,007,550 18,231

Company Background

Shukra Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Shukra Pharmaceuticals Ltd
  • BSE Code : 4083.0
  • ISIN : INE551C01044

  • Incorporation Year

    1993

  • Registered Office

    3 rd Floor Dev House
    Opp WIAA Office Judges Bungalo, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-079-66522247/27498515

  • FAX

  • Chairman

    Dakshesh Shah

  • Managing Director

    Dakshesh Shah

  • Company Secretary

    Arpita Kabraa

  • Auditor

    MAAK & Associates

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Shukra Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shukra Pharma. 13.77 77.39 74.57 62.59 44.16
Abbott India 31,507.40 6,097.18 5,848.91 47.34 44.71
Astrazeneca Phar 9,734.65 1,330.33 1,295.53 210.25 33.26
P & G Health Ltd 5,956.00 1,166.89 1,151.26 39.36 39.76
Glaxosmi. Pharma 3,284.70 3,866.05 3,723.49 60.55 58.72
Cipla 1,498.35 17,645.00 16,574.34 23.46 20.10
Amrutanjan Healt 716.70 437.58 421.23 40.77 20.84
Fermenta Biotec. 327.65 315.24 307.09 14.26 4.10
Guj. Themis Bio. 325.10 174.19 169.82 72.57 44.82
Bliss GVS Pharma 139.80 638.96 605.46 21.34 11.19
Ambalal Sarabhai 36.28 11.70 3.81 33.59 1.92